Analysts Set Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Price Target at $59.13
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP – Get Free Report) has received a consensus rating of “Buy” from the ten research firms that are covering the firm, Marketbeat Ratings reports. Nine investment analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average twelve-month price […]
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP – Get Free Report) has received a consensus rating of “Buy” from the ten research firms that are covering the firm, Marketbeat Ratings reports. Nine investment analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average twelve-month price […]
